We are live on ! Find out more
GIP

Greatmark Investment Partners Portfolio holdings

AUM $906M
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+16.08%
3 Year Est. Return
+61.99%
5 Year Est. Return
+81.88%
10 Year Est. Return
+373.56%
AUM
$250M
AUM Growth
+$6.77M
Cap. Flow
+$3.13M
Cap. Flow %
1.25%
Top 10 Hldgs %
40.75%
Holding
110
New
8
Increased
33
Reduced
35
Closed
3

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$711K
2
HP icon
Helmerich & Payne
HP
+$519K
3
GILD icon
Gilead Sciences
GILD
+$516K
4
GWW icon
W.W. Grainger
GWW
+$510K
5
QCOM icon
Qualcomm
QCOM
+$348K

Top Sells

Rank Stock Value
1
NOV icon
NOV
NOV
+$710K
2
AFL icon
Aflac
AFL
+$218K
3
AAPL icon
Apple
AAPL
+$214K
4
TGNA
TEGNA Inc
TGNA
+$213K
5
JNJ icon
Johnson & Johnson
JNJ
+$172K

Sector Composition

Rank Sector Weight
1 Financials 21.89%
2 Technology 21.19%
3 Healthcare 14.59%
4 Industrials 11.23%
5 Consumer Staples 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MIN
101
Aberdeen Intermediate Income Fund
MIN
$274M
$137K 0.05%
31,769
– –
RDS.A
102
CALL
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$64K 0.03%
+1,200
New +$64.3K
TGT icon
103
CALL
Target
TGT
$67.8B
$42K 0.02%
+800
New +$43.7K
GILD icon
104
CALL
Gilead Sciences
GILD
$163B
$35K 0.01%
+500
New +$33.3K
QCOM icon
105
CALL
Qualcomm
QCOM
$159B
$33K 0.01%
600
– –
TEVA icon
106
CALL
Teva Pharmaceuticals
TEVA
$40.2B
$30K 0.01%
+900
New +$27.9K
ESRX
107
CALL
DELISTED
Express Scripts Holding Company
ESRX
$26K 0.01%
400
– –
NOV icon
108
NOV
NOV
$6.94B
– –
-17,700
Closed -$710K
TDW icon
109
CALL
Tidewater
TDW
$3.55B
– –
-1,705
Closed -$63K
TGNA
110
DELISTED
TEGNA Inc
TGNA
– –
-12,969
Closed -$213K
1 2 3 4
5

Similar funds

SWM
Stockman Wealth Management Billings, Montana $906M AUM 22.23% 1-Year Est. Return
SDWMA
Schneider Downs Wealth Management Advisors Pittsburgh, Pennsylvania $907M AUM 19.33% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
HIGP
Hill Investment Group Partners St. Louis, Missouri $906M AUM 20.13% 1-Year Est. Return
PSCM
Per Stirling Capital Management Austin, Texas $905M AUM 17.06% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM
PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
EI
EnCap Investments Houston, Texas $905M AUM

Greatmark Investment Partners's Q2 2017 Portfolio in Review

As of Q2 2017, Greatmark Investment Partners held 110 positions worth $250M, up 2.8% from $243M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Greatmark Investment Partners's Q2 2017 filing shows 8 new, 33 increased, 35 reduced and 3 closed positions. Its largest new stake was W.W. Grainger: 2,700 shares worth $487K. The largest sale was NOV, an estimated $710K.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Technology and Healthcare.

  • Greatmark Investment Partners's largest Q2 2017 buy was W.W. Grainger: 2,700 shares worth $487K.
  • Greatmark Investment Partners added most to Teva Pharmaceuticals in Q2 2017, an estimated $711K increase.
  • Greatmark Investment Partners's biggest Q2 2017 reduction was Aflac, cutting an estimated $218K.
  • Greatmark Investment Partners fully exited NOV in Q2 2017, selling an estimated $710K.
  • Greatmark Investment Partners's ten largest holdings make up 41% of its $250M portfolio in Q2 2017.
  • Greatmark Investment Partners opened 8 new positions and closed 3 in Q2 2017.
  • Greatmark Investment Partners's portfolio value rose 2.8% quarter-over-quarter to $250M.

Based on Greatmark Investment Partners's 13F filing for Q2 2017, filed 1 Aug 2017.